E-LIB Suche - Ergebnisse für: Spero Cataland

1

Caplacizumab improves clinical outcomes and is well tolerat..:

Pavenski, Katerina ; Scully, Marie ; Coppo, Paul...
Research and Practice in Thrombosis and Haemostasis. 8 (2024) 5 - p. 102512 , 2024

Link: https://doi.org/10.1016/..

2

Subclinical Cardiac Abnormalities in Thrombotic Thrombocyto..:

Danish, Leah ; Sukumar, Senthil ; Cataland, Spero.
Journal of Cardiovascular Magnetic Resonance. 26 (2024) - p. 100802 , 2024

Link: https://doi.org/10.1016/..

3

Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analy..:

Dixon, Bradley P. ; Kavanagh, David ; Aris, Alvaro Domingo Madrid...
Kidney Medicine. 6 (2024) 8 - p. 100855 , 2024

Link: https://doi.org/10.1016/..

4

S305: PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND,..:

Scully, Marie ; Baptista, Jovanna ; Bhattacharya, Indranil...
HemaSphere. 7 (2023) S3 - p. e8651306 , 2023

Link: https://doi.org/10.1097/..

5

Health following recovery from immune thrombotic thrombocyt..:

Kelley, Rachel A. ; Cheney, Marshall K. ; Martin, Clare M....
Blood Advances. 7 (2023) 9 - p. 1813-1822 , 2023

Link: https://doi.org/10.1182/..

6

THE ROLE OF ADAMTS13 ACTIVITY LEVELS ON DISEASE EXACERBATIO..:

KREMER HOVINGA, Johanna ; DE LA RUBIA, Javier ; PAVENSKI, Katerina...
Hematology, Transfusion and Cell Therapy. 45 (2023) - p. S16 , 2023

Link: https://doi.org/10.1016/..

7

Acute GVHD, BK virus hemorrhagic cystitis and age are risk ..:

Vasu, Sumithira ; Bostic, Matthew ; Zhao, Qiuhong...
Blood Advances. 6 (2022) 4 - p. 1342-1349 , 2022

Link: https://doi.org/10.1182/..

8

Long‐term follow‐up of patients treated with caplacizumab a..:

Scully, Marie ; de la Rubia, Javier ; Pavenski, Katerina...
Journal of Thrombosis and Haemostasis. 20 (2022) 12 - p. 2810-2822 , 2022

Link: https://doi.org/10.1111/..

9

LONG-TERM OUTCOMES OF PATIENTS TREATED WITH CAPLACIZUMAB FO..:

Pektaş, Özgür ; Scully, Marie ; Rubia, Javier de la...
Hematology, Transfusion and Cell Therapy. 44 (2022) - p. S33-S34 , 2022

Link: https://doi.org/10.1016/..

10

Comparative efficacy of ravulizumab and eculizumab in the t..:

Tomazos, Ioannis ; Hatswell, Anthony J. ; Cataland, Spero...
Clinical Nephrology. 97 (2022) 5 - p. 261-272 , 2022

Link: https://doi.org/10.5414/..

11

Long-Term Efficacy and Safety of the Long-Acting Complement..:

Barbour, Thomas ; Scully, Marie ; Ariceta, Gema...
Kidney International Reports. 6 (2021) 6 - p. 1603-1613 , 2021

Link: https://doi.org/10.1016/..

12

In vitro diagnostics for the medical dermatologist. Part II..:

Nusbaum, Kelsey B. ; Korman, Abraham M. ; Tyler, Kelly H....
Journal of the American Academy of Dermatology. 85 (2021) 2 - p. 301-310 , 2021

Link: https://doi.org/10.1016/..

13

Caplacizumab prevents refractoriness and mortality in acqui..:

Peyvandi, Flora ; Cataland, Spero ; Scully, Marie...
Blood Advances. 5 (2021) 8 - p. 2137-2141 , 2021

Link: https://doi.org/10.1182/..

14

INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 ST..:

Peyvandi, Flora ; Cataland, Spero ; Scully, Marie...
Hematology, Transfusion and Cell Therapy. 43 (2021) - p. S46-S47 , 2021

Link: https://doi.org/10.1016/..

15

SO054ONE-YEAR EFFICACY AND SAFETY OF THE LONG ACTING C5 INH..:

Kavanagh, David ; Menne, Jan ; Yoon, Sung-Soo...
Nephrology Dialysis Transplantation. 35 (2020) Supplement_3 - p. , 2020

Link: https://doi.org/10.1093/..